Search

Search Constraints

You searched for: Author/Creator Busacca, Anita

Search Results

1. A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease. Issue 1 (8th June 2020)

2. Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment. (November 2021)

3. Real-life experience of infliximab biosimilar in pediatric-onset inflammatory bowel disease: data from the Sicilian Network for Inflammatory Bowel Disease. Issue 10 (14th July 2022)

4. SPOSAB ABP 501 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501. (21st January 2021)

5. SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501. Issue 11 (3rd July 2021)

6. Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival. Issue 7 (July 2022)